Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 107

Minerva seeks divine outcome in $69m IPO

The Proteosys-backed pharmaceutical company, formed through a merger last year, is also set to raise $26m from a concurrent private placement to Johnson & Johnson.

Apr 11, 2014

IDG makes $19m return as Tarena IPO generates almost $138m

IDG's China subsidiary and private equity firm Jafco both achieved partial exits as the education services provider went public raising $137.7m.

Apr 9, 2014

Five9 counts the proceeds as its IPO raises $70m

The SAP-backed company, which is developing software to target the call centre market, has secured $70m in an initial public offering that could rise to $80.5m.

Apr 8, 2014

Truecar to park in public markets

Truecar, an online provider of automotive pricing information that counts USAA and Capital One among its key shareholders, has targeted $125m in its initial public offering.

Apr 8, 2014

Opower up after raising $116m from IPO

Opower, a GE-backed company that uses data analysis to make energy use more efficient, has raised $115.9m from an IPO that could close at more than $133m.

Apr 7, 2014

Imprivata seeks authentic proceeds from $115m IPO

Healthcare authentication and communication company Imprivata, which has raised $32m from investors including SAP Ventures, aims to generate up to $115m from its initial public offering.

Apr 2, 2014

AGTC sees $50m in proceeds from IPO

The biopharmaceutical company, which has investors including the corporate venturing subsidiaries of GlaxoSmithKline and MedImmune, has secured $50m from its initial public offering.

Mar 31, 2014

Opower to generate up to $116m in IPO

The GE-backed energy management company has set the range for an initial public offering that could raise up to $115.9m.

Mar 26, 2014

Versartis grows with $126m IPO

The Amunix-backed biopharmaceutical company could close its initial public offering at almost $145m, and will invest the proceeds in developing its lead drug candidate.

Mar 25, 2014
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here